News and Comments


Recent Postings


Archive


Tags

C4 Therapeutics Abbott Laboratories (ABT) Vitae Pharmaceuticals (VTAE) NANTKWEST (NK) ADVENTRIX (ANX) AstraZeneca (AZN) Regeneron (REGN) SYNTA (SNTA) OSI (OSIP) Biocryst (BCRX) ABBVIE (ABBV) Galena (GALE) Benlysta (belimumab) Anadys (ANDS) Array Pharmaceuticals (ARRY) Velcade (bortezomib) Auspex (ASPX) Mirati Therapeutics (MRTX) IDERA (IDRA) Ariad (ARIA) JUNO (JUNO) ACADIA (ACAD) REGULUS (RGLS) JOUNCE THERAPEUTICS (JNCE) KITE (KITE) Roche (RHHBY) Sanofi (SNA) Amgen (AMGN) Biogen Idec (BIIB) Bristol-Myers Squibb (BMY) Editas (EDIT) INNOVIVA (INVA) Sangamo (SGMO) Vertex (VRTX) ARCA (ABIO) Herceptin Seattle Genetics (SGEN) BIOMARIN (BMRN) Spike Therapeutics (ONCE) RenenxBio (RGNX) CRISPR Therapeutics (CRSP) Alnylam (ALNY) Roche (ROCHE) Dynavax (DVAX) ImmunoGen (IMGN) Cytokinetics (CYTK) Agenus (AGEN AERIE PHARMACEUTICALS Theravance Bio Pharma (TBPH) Pluristem (PSTI) Telaprevir Intrexon (XON) Sanofi-Aventis (SAN) Human Longevity (HLI) NEKTAR (NKTR)) Tysabri Sanofi (SNY) HALOZYME (HALO) Adaptimmune (ADAP) Aimmune Therapeutics (AIMT) Theravance (THRX) Trastuzumab-DM1 Ziofpharm (ZIOP) Multiple Myeloma Micromet (MITI) Prolor Biotech (PBTH) ZALTRAP™ Sequenom (SQNM) Intercept (ICPT) SERES THERAPEUTICS (MCRB) Revlimid (lenolidamide) CEMPRA (CEMP) Onyx (ONXX) MODERNA Bellicum (BLCM) Xoma (XOMA) Prosensa (RNA) galapagos (GLPG) Agenus (AGEN) Sarepta (SRPT) Jazz Pharmaceuticals (JAZZ) Illumina (ILMN) Incyte (INCY) GlaxoSmithKline (GSK) ISIS (ISIS) ARGOS (ARGS) GUARDIAN HEALTH Anacor (ANAC) Rapamune Advaxis (ADXS) Ridaforolimus Inovio (INO) Valeant Pharmaceuticals International (VRX) KERYX (KERX) Ionis (IONS) AGOS (ARGS) Elan (ELN) CompuGen (CGEN) VANDA (VNDA) Global Cell Therapeutics (GBT) NOVOCURE (NVCR) Idenix (IDIX) TOKAI (TKAOI) Human Genome Sciences (HGSI) Merck (MRK) Intermune (ITMN) Endometrial Cancer SUNESIS PHARMACEUTICALS (SNSS) Dendreon (DNDN) Exelixis (EXEL) Alder Biopharmaceuticals (ALDR) PTC Therapeutics (PTCT) PORTOLA (PTLA) Zerenex Gilead (GILD) Genentech Ocular Therapeutix (OCUL)